Ceftin - NDC Database


5 records found:

Sorted by NDC Code

Page of 1
0173-0387 Oct 01, 1989
Ceftin 250 mg Oral Tablet by Glaxosmithkline LLC
0173-0394 Oct 01, 1989
Ceftin 500 mg Oral Tablet by Glaxosmithkline LLC
0173-0740 Jun 02, 2004
Ceftin 125 mg/5ml Oral Powder, for Suspension by Glaxosmithkline LLC
0173-0741 Jun 02, 2004
Ceftin 250 mg/5ml Oral Powder, for Suspension by Glaxosmithkline LLC
54569-4737 Jun 02, 2004
Ceftin 250 mg/5ml Oral Powder, for Suspension by A-s Medication Solutions LLC

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 January 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA